Use of extracorporeal membranous oxygenator in transcatheter aortic valve replacement

George Makdisi, Peter B. Makdisi, I-Wen Wang

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

The superiority of transcatheter aortic valve replacement (TAVR) compared with medical therapy for patients with aortic stenosis (AS) who are not suitable candidates for surgery had been proven. Cardiopulmonary bypass (CPB) is rarely used in TAVR. Reports of early use of extracorporeal membranous oxygenator (ECMO) have promising outcomes. ECMO offers the option of cardiac support rescue in case of intraoperative hemodynamic instability and can be instituted in advance when hemodynamic instability is expected. Here we review the English literature about the use of ECMO in TAVR procedures, and discuss the indications and rationale for its use as well as its advantages.

Original languageEnglish (US)
Article number306
JournalAnnals of Translational Medicine
Volume4
Issue number16
DOIs
StatePublished - Aug 1 2016

Fingerprint

Oxygenators
Hemodynamics
Aortic Valve Stenosis
Cardiopulmonary Bypass
Transcatheter Aortic Valve Replacement
Therapeutics

Keywords

  • Aortic stenosis (AS)
  • Extracorporeal membranous oxygenator (ECMO)
  • TAVI
  • Transcatheter aortic valve replacement (TAVR)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Use of extracorporeal membranous oxygenator in transcatheter aortic valve replacement. / Makdisi, George; Makdisi, Peter B.; Wang, I-Wen.

In: Annals of Translational Medicine, Vol. 4, No. 16, 306, 01.08.2016.

Research output: Contribution to journalReview article

Makdisi, George ; Makdisi, Peter B. ; Wang, I-Wen. / Use of extracorporeal membranous oxygenator in transcatheter aortic valve replacement. In: Annals of Translational Medicine. 2016 ; Vol. 4, No. 16.
@article{6bbcad2ab23d42b596c12e5b7a4077f9,
title = "Use of extracorporeal membranous oxygenator in transcatheter aortic valve replacement",
abstract = "The superiority of transcatheter aortic valve replacement (TAVR) compared with medical therapy for patients with aortic stenosis (AS) who are not suitable candidates for surgery had been proven. Cardiopulmonary bypass (CPB) is rarely used in TAVR. Reports of early use of extracorporeal membranous oxygenator (ECMO) have promising outcomes. ECMO offers the option of cardiac support rescue in case of intraoperative hemodynamic instability and can be instituted in advance when hemodynamic instability is expected. Here we review the English literature about the use of ECMO in TAVR procedures, and discuss the indications and rationale for its use as well as its advantages.",
keywords = "Aortic stenosis (AS), Extracorporeal membranous oxygenator (ECMO), TAVI, Transcatheter aortic valve replacement (TAVR)",
author = "George Makdisi and Makdisi, {Peter B.} and I-Wen Wang",
year = "2016",
month = "8",
day = "1",
doi = "10.21037/atm.2016.08.14",
language = "English (US)",
volume = "4",
journal = "Annals of Translational Medicine",
issn = "2305-5839",
publisher = "AME Publishing Company",
number = "16",

}

TY - JOUR

T1 - Use of extracorporeal membranous oxygenator in transcatheter aortic valve replacement

AU - Makdisi, George

AU - Makdisi, Peter B.

AU - Wang, I-Wen

PY - 2016/8/1

Y1 - 2016/8/1

N2 - The superiority of transcatheter aortic valve replacement (TAVR) compared with medical therapy for patients with aortic stenosis (AS) who are not suitable candidates for surgery had been proven. Cardiopulmonary bypass (CPB) is rarely used in TAVR. Reports of early use of extracorporeal membranous oxygenator (ECMO) have promising outcomes. ECMO offers the option of cardiac support rescue in case of intraoperative hemodynamic instability and can be instituted in advance when hemodynamic instability is expected. Here we review the English literature about the use of ECMO in TAVR procedures, and discuss the indications and rationale for its use as well as its advantages.

AB - The superiority of transcatheter aortic valve replacement (TAVR) compared with medical therapy for patients with aortic stenosis (AS) who are not suitable candidates for surgery had been proven. Cardiopulmonary bypass (CPB) is rarely used in TAVR. Reports of early use of extracorporeal membranous oxygenator (ECMO) have promising outcomes. ECMO offers the option of cardiac support rescue in case of intraoperative hemodynamic instability and can be instituted in advance when hemodynamic instability is expected. Here we review the English literature about the use of ECMO in TAVR procedures, and discuss the indications and rationale for its use as well as its advantages.

KW - Aortic stenosis (AS)

KW - Extracorporeal membranous oxygenator (ECMO)

KW - TAVI

KW - Transcatheter aortic valve replacement (TAVR)

UR - http://www.scopus.com/inward/record.url?scp=85006201187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006201187&partnerID=8YFLogxK

U2 - 10.21037/atm.2016.08.14

DO - 10.21037/atm.2016.08.14

M3 - Review article

AN - SCOPUS:85006201187

VL - 4

JO - Annals of Translational Medicine

JF - Annals of Translational Medicine

SN - 2305-5839

IS - 16

M1 - 306

ER -